Parker Institute (@parkerici) header
Parker Institute (@parkerici) profile picture

Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.

San Francisco, CA
Joined February 2016
Parker Institute retweeted
Honored to moderate a fantastic panel on a key bottleneck in #celltherapy @parkerici @US_FDA @AllogeneTx @AstraZeneca @IovanceBio
Sometimes split starting material equivalence testing is not easy, or is simply impractical — whether due to limitations on starting material that make split studies at scale impossible, or because the original sending site is no longer available. - Marc Better, Pharmefex
2
1
7
2,059
Last chance to register! Join us Wednesday in DC or virtually for our "Unlocking Next-Generation Therapies" meeting: bit.ly/4sZadyf. This free event will bring together experts across industries to explore innovative approaches in cell therapy development.
4
4
1,194
Parker Institute retweeted
Fantastic collaboration between ⁦@GuardantHealth⁩ and ⁦@parkerici⁩ Methyl-based ctDNA tumor fraction changes predict long-term clinical benefit from immune checkpoint inhibitors in RADIOHEAD, a real-world pan-cancer study aacrjournals.org/cancerresco…
2
13
1,153
At #SITC25 Ira Mellman of the @parkerici and Medici Therapeutics will be honored for the 2025 Richard V. Smalley Memorial Award and Lectureship! He will give a presentation on Nov. 8 – join virtually or attend in person. sitcancer.org/2025/home
2
6
1,165
Parker Institute retweeted
Collection highlight from @Cancer_Cell: Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy hubs.li/Q03x0gSB0 @PennMedicine
1
36
1
132
7,351
Parker Institute retweeted
With solid tumors representing ~90% of cancers, Dispatch Bio is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform to help create a world where all #cancer patients can be cured. Learn more: dispatchbio.com/news/dispatc…
1
6
4
13
1,534
Parker Institute retweeted
We’re proud to announce that Elizabeth Mittendorf, MD, will join BIDMC as Chief of a new Division of Breast Surgery! 👏 A renowned surgeon, she will bring bold leadership to our growing program in collaboration with Dana-Farber. Learn more: bidmc.org/about-bidmc/news/2…
5
10
9
53
15,508
Parker Institute retweeted
𝐂𝐀𝐑-𝐓 𝐋𝐨𝐠𝐢𝐜-𝐆𝐚𝐭𝐢𝐧𝐠: @ArsenalBio CEO @KDrazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed. Full interview: biotechtv.com/post/arsenalbi…
1
5
1
18
4,024
Parker Institute retweeted
Share your #cancer #immunology research w/ #CSCancerImmunity2025 organizers Ignacio Melero @unav, Ira Mellman @parkerici, Fabiola Rivas, @ImmunityCP & Montse Rojo de la Vega @Cancer_Cell. Abstract deadline July 25 hubs.li/Q03tjTxS0
10
16
3,735
Ira Mellman, the new president of research at the Parker Institute for Cancer Immunotherapy (@parkici), asks why so many drug developers are retreating from cancer immunotherapies before they have achieved their full potential in our latest interview nature.com/articles/d41573-0…
5
1
24
3,640
New #JITC review: Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials bit.ly/4dTQf0V @John_E_Connolly
5
19
1,483
Parker Institute retweeted
thank you, @CancerResearch -- we are fired up and ready to make some bold moves
🌟 Meet the 2025 Lloyd J. Old STARs- five extraordinary rising scientific leaders whose work is pushing the boundaries of what’s possible in cancer immunotherapy! Discover: bit.ly/4kFIjmo #CancerResearch #Immunotherapy (1/2)
1
2
41
4,491
Parker Institute retweeted
Here's our latest, led by superstars @JoYatesResearch & Dr. Camille Mathey-Andrews, jointly with @val_boeva and many more @DanaFarberNews @broadinstitute We studied primary & lethal esophageal cancer using multi[RNA, ATAC, spatial]-omics, see Josephine's tweets below for more!👇
Thrilled to share our new paper out today in Cell Reports Medicine! @VanAllenLab @val_boeva We map cell states & neighborhoods across clinical stages of esophageal adenocarcinoma (EAC) using single-cell, epigenomic & spatial data.🔗cell.com/cell-reports-medici… (1/9)
2
13
65
9,781
Parker Institute retweeted
🚨 New Preprint 🚨 A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype How can we tune JAK/STAT signaling to create better immune cell therapies? doi.org/10.1101/2025.06.05.6…
12
55
7
184
20,306